With the ongoing conversation of drug costs and it's ill-effects on cancer patients, I decided to go ahead and share this Forbes article. The author's final comment encapsulates it best: "High prices may be needed to fuel the fire of innovation, but while the drug industry keeps saying that they enable the pursuit of rare prizes, the market is telling us the opposite: that prices have become the prize."
